NCEL
NewcelX Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 7/1/2026 | View on SEC |
| 6-K | 6/30/2026 | View on SEC |
| EFFECT | 6/17/2026 | View on SEC |
| 6-K | 6/15/2026 | View on SEC |
| F-3/A | 6/10/2026 | View on SEC |
| 6-K | 6/5/2026 | View on SEC |
| 6-K | 5/27/2026 | View on SEC |
| EFFECT | 5/15/2026 | View on SEC |
| D | 5/13/2026 | View on SEC |
| F-3 | 5/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NCEL |
| Company Name | NewcelX Ltd. |
| CIK | 1783036 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | V8 |
| Phone | 41-41-618-80-00 |